MATERA, Maria Gabriella

MATERA, Maria Gabriella  

Dipartimento di Medicina Sperimentale  

Risultati 1 - 20 di 363 (tempo di esecuzione: 0.014 secondi).
Titolo Data di pubblicazione Autore(i) File
1. New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol. 1-gen-2013 Cazzola, M; Segreti, A; Matera, Maria Gabriella
10. Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease. 1-gen-2013 Cazzola, M; Rogliani, P; Matera, Maria Gabriella
5-HT modifiers as a potential treatment of asthma 1-gen-2000 Cazzola, I; Matera, Maria Gabriella
A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease 1-gen-1996 Matera, Maria Gabriella; Caputi, M; Cazzola, M.
A comparison of bronchodilating effects of salmeterol and oxitropium bromide in stable chronic obstructive pulmonary disease 1-gen-1998 Cazzola, M; Matera, Maria Gabriella; DI PERNA, F; Calderaro, F; Califano, C; Vinciguerra, A.
A comparison of sensory nerve function in human, guinea-pig, rabbit and marmoset airways 1-gen-1998 Spina, D; Matera, Maria Gabriella; Riccio, Mm; Page, Cp
A comparison of the bronchodilating effects of salmeterol, salbutamol and ipratropium bromide in patients with chronic obstructive pulmonary disease 1-gen-1995 Matera, Maria Gabriella; Cazzola, M; Vinciguerra, A; DI PERNA, F; Calderaro, F; Caputi, M; Rossi, Francesco
A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD 1-gen-2003 Cazzola, M; Santus, P; Matera, Maria Gabriella; Carlucci, P; Belloli, E; DI MARCO, F; Centanni, S.
ACE2: The Major Cell Entry Receptor for SARS-CoV-2 1-gen-2020 Scialo, F.; Daniele, A.; Amato, F.; Pastore, L.; Matera, M. G.; Cazzola, M.; Castaldo, G.; Bianco, A.
Aclidinium bromide for the treatment of chronic obstructive pulmonary disease. 1-gen-2013 Cazzola, M; Page, Cp; Matera, Maria Gabriella
Aclidinium bromide inhalation powder for the long-term, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease including chronic bronchitis and emphysema 1-gen-2016 Matera, Maria Gabriella; Sanduzzi, Alessandro; Alfano, Roberto; Cazzola, Mario
Acute effects of higher than customary doses of salmeterol and salbutamol in patients with acute exacerbation of COPD. 1-gen-2002 Cazzola, M; Califano, C; Di Perna, F; D'Amato, M; Terzano, C; Matera, Maria Gabriella; D'Amato, G; Marsico, S. A.
Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple therapy in COPD 1-gen-2019 Calzetta, Luigino; Cazzola, Mario; Matera, Maria Gabriella; Rogliani, Paola
Addition of an extra dose of salmeterol Diskus to conventional dose of salmeterol Diskus in patients with COPD 1-gen-2002 Cazzola, M; Santus, P; Castagna, F; DI MARCO, F; Terzano, C; Matera, Maria Gabriella; Centanni, S.
Additional clinical benefit of enoxaparin in COPD patients receiving salmeterol and fluticasone propionate in combination 1-gen-2006 Brown, Ra; Allegra, L; Matera, Maria Gabriella; Page, Cp; Cazzola, M.
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study 1-gen-2007 Cazzola, M; Matera, Maria Gabriella
Adenosine receptors: novel targets for drug development in allergic rhinitis 1-gen-2007 Matera, Maria Gabriella; Polosa, R.
Adherence to COPD treatment: Myth and reality 1-gen-2017 Rogliani, Paola; Ora, Josuel; Puxeddu, Ermanno; Matera, Maria Gabriella; Cazzola, Mario
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond. 1-gen-2014 Calzetta, L; Rogliani, P; Cazzola, M; Matera, Maria Gabriella
Advances in the Pharmacological Management of Pediatric Acute Respiratory Distress Syndrome 1-gen-2022 Matera, M. G.; Imperatore, F.; Annibale, R.; Cazzola, M.